Stevanato group files amendment no.1 to its 2021 annual report on form 20‑f/a

Piombino dese, italy--(business wire)--stevanato group s.p.a. (nyse: stvn), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced the filing of amendment no. 1 (the “form 20-f/a”) to its 2021 annual report on form 20-f (the “form 20-f”), which was filed with the u.s. securities and exchange commission (the “sec”) on march 8, 2022, to submit the interactive data file and to provide cert
STVN Ratings Summary
STVN Quant Ranking